CoChat

Intramuscular desferrioxamine in patients with Alzheimer's disease

MCLACHLAN, D · 1991 · The Lancet

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Although epidemiological and biochemical evidence suggests that aluminium may be associated with Alzheimer's disease (AD), there is no convincing proof of a causal link for aluminium in disease progression. We have completed a two year, single-blind study to investigate whether the progression of dementia could be slowed by the trivalent ion chelator, desferrioxamine. 48 patients with probable AD were randomly assigned to receive desferrioxamine (125 mg intramuscularly twice daily, 5 days per week, for 24 months), oral placebo (lecithin), or no treatment. No significant differences in baseline measures of intelligence, memory, or speech ability existed between groups. Activities of daily living were assessed and videorecorded at 6, 12, 18, and 24 month intervals. There were no differences in the rate of deterioration of patients receiving either placebo or no treatment. Desferrioxamine treatment led to significant reduction in the rate of decline of daily living skills as assessed by both group means (p = 0.03) and variances (p less than 0.04). The mean rate of decline was twice as rapid for the no-treatment group. Appetite (n = 4) and weight (n = 1) loss were the only reported side-effects. We conclude that sustained administration of desferrioxamine may slow the clinical progression of the dementia associated with AD.

Overview

Integrity signals

Registry

Crossref · 10.1016/0140-6736(91)92978-b

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 19 references

Cited by

See all 764

Metadata

Authors
MCLACHLAN, D.
Venue
The Lancet
Publisher
Elsevier BV
Published
1991-06
Volume
337
Issue
8753
Pages
1304-1308
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2054113864
Cited by
764
References
19
Citations by year
2026: 18 · 2025: 31 · 2024: 30 · 2023: 34 · 2022: 25 · 2021: 28 · 2020: 32 · 2019: 26 · 2018: 23 · 2017: 19 · 2016: 26 · 2015: 23 · 2014: 27 · 2013: 15 · 2012: 22
FWCI
18.11
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Aluminum toxicity and tolerance in plants and animals
Keywords
deferoxamine, Alzheimer's disease, aluminum, dementia progression, activities of daily living, intramuscular administration, adverse effects
MeSH terms
Aged, Alzheimer Disease, Analysis of Variance, Chromatography, High Pressure Liquid, Deferoxamine, Female, Humans, Injections, Intramuscular, Male, Middle Aged, Prospective Studies, Psychological Tests, Single-Blind Method

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intramuscular desferrioxamine in patients with Alzheimer's disease. https://app.cochat.ai/papers/10.1016/0140-6736(91)92978-b
The paper
MCLACHLAN, D. (1991). Intramuscular desferrioxamine in patients with Alzheimer's disease. The Lancet. https://doi.org/10.1016/0140-6736(91)92978-b

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.